Ventolin and Olmesartan medoxomil drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ventolin (albuterol) and Olmesartan medoxomil (olmesartan medoxomil). Common drug interactions include nausea among females and jaundice among males.

The phase IV clinical study analyzes what interactions people have when they take Ventolin and Olmesartan medoxomil. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Ventolin?

Ventolin has active ingredients of albuterol. It is often used in asthma. eHealthMe is studying from 51,849 Ventolin users. Check the latest studies of Ventolin.

What is Olmesartan medoxomil?

Olmesartan medoxomil has active ingredients of olmesartan medoxomil. It is often used in high blood pressure. eHealthMe is studying from 15,240 Olmesartan medoxomil users. Check the latest studies of Olmesartan medoxomil.

On Jul, 26, 2026

17 people who take Ventolin and Olmesartan medoxomil together, and have interactions are studied.

Ventolin and Olmesartan medoxomil drug interactions.

What are the common drug interactions of Ventolin and Olmesartan Medoxomil, by gender? *:

female:

Nausea (feeling of having an urge to vomit)
Sinusitis (inflammation of sinus)
Upper respiratory tract infection
Diarrhoea
Neuroleptic malignant syndrome (a life-threatening neurological disorder most often caused by an adverse reaction to neuroleptic or antipsychotic agents)
Staphylococcal sepsis (blood infection by an infection with staphylococcus bacteria)
Aplasia (defective development or congenital absence of an organ or tissue)
Blood pressure systolic increased
Bone marrow failure
Candida sepsis (candida in blood stream)

male:

Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
Liver injury
Hepatic cyst
Lung infection
Abnormal weight gain
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Infective exacerbation of chronic obstructive airways disease (severe infective lung disease with chronic obstructive airways disease)

What are the common drug interactions of Ventolin and Olmesartan Medoxomil, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Abnormal weight gain
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Dysgeusia (disorder of the sense of taste)
Malaise (a feeling of general discomfort or uneasiness)
Mouth ulceration (mouth ulcers)

60+:

Back pain
Headache (pain in head)
Lung infection
Neuroleptic malignant syndrome (a life-threatening neurological disorder most often caused by an adverse reaction to neuroleptic or antipsychotic agents)
Staphylococcal sepsis (blood infection by an infection with staphylococcus bacteria)
Aplasia (defective development or congenital absence of an organ or tissue)
Blood pressure systolic increased
Bone marrow failure
Candida sepsis (candida in blood stream)
Candidiasis (candidiasis or thrush is a fungal infection)

What are the existing conditions these people have? *

Type 2 Diabetes: 4 people, 23.53%
Lung Infection: 4 people, 23.53%
High Blood Cholesterol: 4 people, 23.53%
Psoriasis (immune-mediated disease that affects the skin): 2 people, 11.76%
Parkinson's Disease: 2 people, 11.76%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 1 person, 5.88%
Immunodeficiency Common Variable: 1 person, 5.88%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 1 person, 5.88%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 5.88%
Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Ventolin and Olmesartan medoxomil?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously